Global law firm White & Case LLP has advised CM Life Sciences, a special purpose acquisition company (SPAC) on its agreement to combine with Sema4, a patient-centered health intelligence company leveraging AI and machine learning to derive data-driven insights.
Prior to the business combination, CM Life Sciences was founded to take advantage of a dynamic yet fragmented life sciences sector buoyed by innovation consisting of many under-resourced and under-scaled companies. Significant and under-appreciated opportunities for consolidation were ready for engagement by a team versed in current trends and industry themes, and who could bring together the strongest of the new companies and management teams to capitalize on near- and far-term opportunities.
The White & Case team that advised on the transaction was led by partners Matthew Kautz, Joel Rubinstein, Colin Diamond and Steven Gee, and included partners Henrik Patel, Scott Weingaertner and Andres Liivak; associates Patrick Mock, Joseph Chung, Joanna Heinz, Peter Shelburne and Kelly Funderburk, all in New York; associates Adam Arnett and Eric Clamage in Chicago; partner Rebecca Farrington, counsel Paul Pittman and associates Kyle Levenberg and Daniela Huerta Garcia, all in Washington, DC, and associate Ted Seeger in Houston.
For more information please speak to your local media contact.